ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies

ClinicalTrials.gov ID: NCT05379634

Public ClinicalTrials.gov record NCT05379634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies

Study identification

NCT ID
NCT05379634
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
36 participants

Conditions and interventions

Conditions

Interventions

  • Glucocorticoids Drug
  • Nipocalimab Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 4, 2022
Primary completion
Sep 3, 2025
Completion
Sep 15, 2026
Last update posted
Apr 12, 2026

2022 – 2026

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
18
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Research PLLC Phoenix Arizona 85032
HonorHealth Neurology Scottsdale Arizona 85251
Attune Health Autoimmune and Inflamation Care and Research Beverly Hills California 90211
University of California Irvine Medical Center Orange California 92868
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance California 90502
FM Clinical Research, LLC South Florida Neurology Associates, P. A. Boca Raton Florida 33487
Integral Rheumatology And Immunology Specialists Plantation Florida 33324
University of South Florida Tampa Florida 33612
Augusta University Augusta Georgia 30912
University of Kansas Medical Center Kansas City Kansas 66160
Johns Hopkins University Baltimore Maryland 21224
The Brigham and Women's Hospital, Inc. Boston Massachusetts 02115
Clinical Research Institute of Michigan, LLC Saint Clair Shores Michigan 48081
Wexner Medical Center at the Ohio State University Columbus Ohio 43203
Oregon Health and Science University Portland Oregon 97239
University of Pennsylvania - Perelman School of Medicine Philadelphia Pennsylvania 19104
ACME Research Arthritis and Osteoporosis Center Orangeburg South Carolina 29118
Nervie and Muscle Center of Texas Houston Texas 77030
University of Texas at Houston Medical School Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05379634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05379634 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →